system
A chat on subreddit /r/wallstreetbets
human
Nash is the disease Viking is focused on developing a drug for. Gilead has delayed results but I was pretty high on a company called GALT before. It's been awhile since I tracked it but it seems there hasnt been any advancements lately

gpt
Viking is NAFLD, MDGL is NASH. 
  
 If you want the winner, its gonna be MDGL, but with that being said, it fell from its highs because I think a lot of people think the NASH market is overstated. I can see MDGL being taken out as a M&amp;A candidate before approval in 2021, but this may drop to the 50s if BeRnIe or WaRrEn gets the nomnom.